Cladis Investment Advisory, LLC Johnson & Johnson Transaction History

Cladis Investment Advisory, LLC

  • $138 Billion
  • Q1 2025

A detailed history of Cladis Investment Advisory, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 3,649 shares of JNJ stock, worth $552,203. This represents 0.44% of its overall portfolio holdings.

Number of Shares
3,649
Previous 3,798 3.92%
Holding current value
$552,203
Previous $549 Million 10.15%
% of portfolio
0.44%
Previous 0.39%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$142.06 - $167.7 $21,166 - $24,987
-149 Reduced 3.92%
3,649 $605 Million
Q4 2024

Feb 14, 2025
SELL
$143.34 - $165.86 $79,697 - $92,218
-556 Reduced 12.77%
3,798 $549 Million
Q3 2024

Nov 14, 2024
BUY
$145.48 - $167.38 $18,185 - $20,922
125 Added 2.96%
4,354 $706 Million
Q2 2024

Oct 09, 2024
BUY
$144.38 - $157.78 $9,529 - $10,413
66 Added 1.59%
4,229 $618 Million
Q2 2024

Aug 14, 2024
BUY
$144.38 - $157.78 $9,529 - $10,413
66 Added 2.09%
3,229 $471,000
Q1 2024

Oct 09, 2024
BUY
$155.22 - $162.74 $144,975 - $151,999
934 Added 28.93%
4,163 $659 Million
Q1 2024

May 13, 2024
SELL
$155.22 - $162.74 $72,953 - $76,487
-470 Reduced 12.94%
3,163 $500,000
Q4 2023

Oct 09, 2024
BUY
$145.6 - $158.88 $21,840 - $23,832
150 Added 3.35%
4,633 $726 Million
Q4 2023

Feb 13, 2024
BUY
$145.6 - $158.88 $21,840 - $23,832
150 Added 4.31%
3,633 $569,000
Q3 2023

Oct 09, 2024
BUY
$155.75 - $174.48 $195,310 - $218,797
1,254 Added 38.84%
4,483 $698 Million
Q3 2023

Nov 13, 2023
SELL
$155.75 - $174.48 $15,575 - $17,448
-100 Reduced 2.79%
3,483 $542,000
Q2 2023

Oct 09, 2024
BUY
$154.35 - $166.11 $4,013 - $4,318
26 Added 0.57%
4,583 $759 Million
Q2 2023

Aug 11, 2023
BUY
$154.35 - $166.11 $4,013 - $4,318
26 Added 0.73%
3,583 $593,000
Q1 2023

Oct 09, 2024
BUY
$151.05 - $180.26 $200,594 - $239,385
1,328 Added 41.13%
4,557 $706 Million
Q1 2023

May 15, 2023
BUY
$151.05 - $180.26 $58,909 - $70,301
390 Added 12.31%
3,557 $551,000
Q3 2022

Oct 09, 2024
BUY
$161.33 - $179.52 $151,327 - $168,389
938 Added 29.05%
4,167 $681 Million
Q3 2022

Nov 17, 2022
BUY
$161.33 - $179.52 $510,932 - $568,539
3,167 New
3,167 $517,000
Q1 2022

May 10, 2022
SELL
$158.14 - $179.59 $508,578 - $577,561
-3,216 Closed
0 $0
Q4 2021

Oct 08, 2024
SELL
$155.93 - $173.01 $2,027 - $2,249
-13 Reduced 0.4%
3,216 $550 Million
Q4 2021

Oct 01, 2024
SELL
$155.93 - $173.01 $2,027 - $2,249
-13 Reduced 0.4%
3,216 $550 Million
Q4 2021

May 10, 2022
BUY
$155.93 - $173.01 $501,470 - $556,400
3,216 New
3,216 $550,000

Others Institutions Holding JNJ

# of Institutions
4,651
Shares Held
1.73B
Call Options Held
25M
Put Options Held
15.1M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $396B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cladis Investment Advisory, LLC Portfolio

Follow Cladis Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email